News

The AMR Centre secures £2.3m funding boost

The AMR Centre, a body with public and private investors leading the UK’s response to the global health threat posed by antimicrobial resistance, has received a significant funding package to support the expansion of its pipeline of new drugs to treat drug-resistant infections.

The package totals £2.3m and is led by an investment from LifeArc, one of the UK’s foremost medical research charities. Other backers include Bruntwood SciTech, MGL, and the Greater Manchester and Cheshire Life Sciences Fund.

PredictImmune win Business Weekly Life Science Innovation (Product) award

Developers of pioneering prognostic tools recognised for its innovative product development and contribution to life science discovery

Cambridge, UK, 21 March 2019: PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, are delighted to have been awarded the Life Science Innovation award for product development at the annual Business Weekly awards.

Arecor receives regulatory approval to initiate phase I clinical trial for ultra-rapid acting insulin product

Arecor Limited, the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that a Phase I Clinical Trial Application (“CTA”) for product candidate AT247 has been approved by the Bundesamt für Sicherheit im Gesundheitswesen (BASG), the Austrian Federal Office for Safety in Health Care.

Apply to present at the 2019 Babraham Investor Conference

Babraham Research Campus is offering companies seeking funding the opportunity to present at its 10^th investor conference

Babraham 18th March 2018: The Babraham Investor Conference (BIC) is back to bring together like-minded investors focussed on early-stage and scale-up life science and med-tech opportunities.

And now, companies seeking funding of between £250K to £20M have the opportunity to pitch to an audience of potential investors on 15 May at the Babraham Research Campus, Cambridge.

New appointments strengthen the Aigenpulse Leadership team

Aigenpulse Ltd., (Aigenpulse), a big data technology company which specialises in structuring, integrating and deriving meaning from large, disparate data assets in the life sciences sector, is continuing to strengthen its management team with the addition of Head of Delivery and Head of DevOps.

Fisher Scientific Channel Names Corning Life Sciences as European Supplier of the Year

LOUGHBOROUGH, England (March 13, 2019) – Thermo Fisher Scientific, the world leader in serving science, recently announced the winners of the Fisher Scientific Channel Supplier Awards during its annual Fisher Scientific European Sales Conference held in Poland.

From March 4-7, 2019, almost 750 delegates attended the Fisher Scientific European Sales Conference at the Gołębiewski Hotel, Karpacz, Poland. This was the eighth event of its kind, bringing together delegates from 21 different countries.

LabKey to create Sample Management Platform 2019

SAMPLE MANAGEMENT

Due to its flexibility to be configured to address a wide spectrum of data challenges within the research environment, LabKey Server has long been assumed to be a LIMS system. It's true, LabKey can be used as fundamental sample management / tracking / processing tool. Things are about to get even more interesting !

PredictImmune announce formal entry of PredictSURE IBD™ into the NICE Diagnostic Assessment Programme

Evaluation by the Diagnostic Assessment Programme provides independent support and validation of PredictImmune’s first product addressing IBD

Cambridge, UK, 12 March 2019: PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today announced the formal entry of its first product, PredictSURE IBD™, into NICE’s Diagnostic Assessment Programme (DAP).

Arecor appoints Chief Financial Officer

Arecor Limited, the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, is pleased to announce the appointment of Susan Lowther as Chief Financial Officer. Susan was appointed to the board with effect from 4th March 2019.

Inivata Publishes Positive Results of Clinical Validation and Utility Study for InVision® Liquid Biopsy Test

Large, real-world, prospective study shows Inivata’s liquid biopsy test is able to provide molecular profile when tissue is unavailable and guide personalized treatment

High levels of concordance, sensitivity and specificity validate InVision in advanced NSCLC

My Account